# A Dose Escalating Study of HC002 in Healthy Adult Volunteers

> **NCT06670274** · PHASE1 · COMPLETED · sponsor: **Holoclara Aus Pty Ltd** · enrollment: 56 (actual)

## Conditions studied

- Inflammatory Disease
- Autoimmune Diseases

## Interventions

- **DRUG:** HC002 SAD
- **DRUG:** HC002 MAD
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06670274
- **Lead sponsor:** Holoclara Aus Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-21
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-05-07
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06670274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06670274, "A Dose Escalating Study of HC002 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06670274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*